Why Tandem Diabetes Care Stock Popped Today
The Motley Fool
by newsfeedback@fool.com (Joe Tenebruso)February 21, 2026
AI-Generated Deep Dive Summary
Tandem Diabetes Care (TNDM) stock surged by over 32% today after reporting significant improvements in profitability and a shift toward a more predictable and lucrative business model. The company, an insulin delivery specialist, revealed strong fourth-quarter sales growth of 3% year over year to $290 million, with worldwide shipments reaching 38,000 pumps, including 27,000 in the U.S. A new pay-as-you-go pharmacy structure has reduced upfront costs for customers while generating recurring revenue for Tandem, contributing to a notable increase in gross margin from 56% to 58% and transforming an operating loss of $0.6 million into a profit of $8.3 million.
This transformation was highlighted by CEO John Sheridan as a defining
Verticals
financeinvesting
Originally published on The Motley Fool on 2/21/2026